Participants received either placebo or HPS ( 9.68 g of HPS at once , three times daily ) for 4-weeks , and the efficacy evaluations were performed by assessing the Nepean Dyspepsia Index ( NDI ) and functional dyspepsia-quality of life ( FD-QoL ) at 0 - , 4 - and 8-weeks .